期刊文献+

妊娠中期血清标记物检测在唐氏综合征产前筛查中的意义 被引量:7

Effectiveness of second trimester serum marker screening for Down's syndrome
暂未订购
导出
摘要 目的探讨妊娠中期血清标记物在唐氏综合征(DS)产前筛查中的意义。方法分别用血清二联筛查与三联筛查方法进行孕中期胎儿唐氏综合征产前筛查试验,孕妇胎龄为15~21周,对两种筛查方法的检出率及假阳性率进行分析,同时结合ROC曲线分析两种血清筛查方法的敏感性并相互比较。结果在5 063例孕妇中6例为DS胎儿,二联和三联筛查的DS检出率分别是50%和83.3%,假阳性率分别为2.2%和2.1%,ROC分析得到的曲线下面积(AUC)分别为0.62(95%CI:0.583~0.707)和0.85(95%CI:0.795~0.880)。结论孕中期血清筛查胎儿DS试验具有很好的参考价值,而血清三联筛查方法明显优于血清二联筛查。 To investigate the effectiveness of serum markers analysis for Down' s syndrome (DS) during the second trimester prenatal screening. Methods Second trimester screening for DS were examined in pregnant women with a singleton pregnancy of 15 -21 weeks of gestation by double serum marker screening and triple screening methods. Results With double marker and triple marker analysis, the detection rate of DS were 50% and 83.3%, false positive rate were 2.2% and 2.1% respectively. With receiver operating characteristic curve (ROE) analysis, area under the curve (AUC) were 0.62 (95% CI: 0.583-0.707) and 0.85 (95 % CI : 0. 795 - 0. 880 ) respectively. Conclusion screening using serum is more effective than marker analysis has a rattling reference value, double marker analysis for detection of DS. Second trimester prenatal and triple marker analysis
出处 《哈尔滨医科大学学报》 CAS 北大核心 2012年第4期367-369,共3页 Journal of Harbin Medical University
基金 哈尔滨市科技创新人才专项资金项目(RC2007XK00-4033)
关键词 唐氏综合征 产前筛查 妊娠中期 Down' s syndrome prenatal screening second trimester
  • 相关文献

参考文献10

  • 1景春梅,王应雄.唐氏综合征产前筛查的研究进展[J].国外医学(计划生育.生殖健康分册),2006,25(6):314-318. 被引量:3
  • 2Olson LE, Richtsmeier JT, Leszl J, et al. A chromosome 21 criti- cal region does not cause specific Down syndrome phenotypes[ J]. Science, 2004, 306(5696) : 687-690.
  • 3Beak KH, Zaslavsky A, Lynch RC, et al. Down's syndrome sup- pression of tumour growth and the role of the calcineurin inhibitor DSCRI[J]. Nature, 2009,459(7250) : 1126-1130.
  • 4Roizen NJ, Patterson D. Down' s syndrome [ J ]. Lancet, 2003, 361 (9365) : 1281-1289.
  • 5Go AT, Visser A, Mulders MA, et al. C21ORF105,A chromo- some 21-encoded mRNA, is not a discriminative marker gene for prediction of Down syndrome in maternal plasma [ J ]. Prenat Di- agn, 2007, 27(2) :146-149.
  • 6Huang T, Boucher K, Summers AM. Second trimester prenatal screening for Down syndrome:the associations between the levels of serum markers in successive pregnancies [ J ]. Prenat Diagn, 2007, 27(12) : 1138-1142.
  • 7Van Dyke DL, Ebrahim SA, A1 Saadi AA, et al. The impact of maternal serum screening programs for Down syndrome in southeast Michigan, 1988-2003 [ J ]. Prenat Diagn, 2007, 27 ( 6 ) : 583- 584.
  • 8Spencer K. Age related detection and false positive rates when screening for Down's syndrome in the first trimester using fetal nu- chal translucency and maternal serum free 13-hCG and PAPP-A [J]. Br J Obstet Gynaeeol, 2001, 108(10) : 1043-1046.
  • 9Forest JC, Mass6 J, Moutquin JM. Sereening for Down syndrome during fist trimester: a prospective study using free B-human ehori- onie gonadotropin and pregnancy-associated plasma protein A[ J]. Clin Biochem, 1997, 30(4) :333-338.
  • 10Caniek JA, MacRae AR. Second trimester serum markers [ J ]. Semin Perinatol, 2005, 29(4) :203-208.

二级参考文献20

  • 1Clementi M, Bianca S,Tenconi R. Re: "parity and the risk of Down's syndrome". Am J Epidemiol,2004, 160(6) :610
  • 2Dzurova D,Pikhart H.Down syndrome, paternal age and education:comparison of California and the Czech Republic. BMC Public Health,2005,5 ( 1 ) :69
  • 3Spencer K. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays. Ann Clin Biochem,2005,42 (pt 1 ):30-40
  • 4Bersinger NA,Wunder D, Vanderlick F,et al. Maternal serum levels of placental proteins after in vitro fertilisation and their implications for prenatal screening. Prenat Diagn, 2004,24 (6) :471-477
  • 5Christiansen M. Norgaard-Pedersen B.Inhibin A is a maternal serum marker for Down's syndrome early in the first trimester.Clin Genet,2005,68 ( 1 ):35-39
  • 6Locatelli A, Mariani S, Ciriello E,et al.Role of FISH on uncultured amniocytes for the diagnosis of aneuploidies in the presence of fetal anomalies.Fetal Diagn Ther, 2005,20( 1 ):1-4
  • 7Witters I, Devriendt K, Legius E, et al. Rapid prenatal diagnosis of trisomy 21 in 5049 consecutive uncultured amniotic fluid samples by fluorescence in situ hybridisation (FISH). Prenat Diagn, 2002, 22( 1 ): 29-33
  • 8Zimmermann B,El-Sheikhah A,Nicolaides K, et al. Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma. Clin Chem,2005,51 ( 9 ): 1598-1604
  • 9Yang YH, Nam MS, Yang ES. Rapid prenatal diagnosis of trisomy 21 by real-time quantitative polymerase chain reaction with amplification of small tandem repeats and S100B in chromosome 21.Yonsei Med J, 2005,46 (2): 193-197
  • 10Ochshom Y, Bar-Shira A, Jonish A, et al. Rapid prenatal diagnosis of aneuploidy for chromosomes 21, 18, 13, and X by quantitative fluorescence polymerase chain reaction. Fetal Diagn Ther, 2006,21(4): 326-331

共引文献2

同被引文献63

引证文献7

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部